This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Successfully funded
Capital at risk
overfunded
Ultramed
317%
Raised
£317,540
Investors
473
Target
£100,000
Equity
17.47%
Pre-money valuation
£1,500,000

Ultramed is a health tech company, placing innovation and patient experience at the forefront of their strategy. Combining clinical NHS operative experience, they operate a suite of cloud based pre operative products. The aim is to reduce costs and free up health care resources.

  • £65m could be saved if the NHS adopted digital preoperative assessment
  • The NHS performs 10 million procedures per annum
  • The founding team has broad commercial and clinical skills
  • Initial funding of £130k has allowed products to be commercialised

Idea

Ultramed operates a suite of online patient completed pre-procedure assessment programs under the Ultraprep trademark. The aim is to reduce costs and free up health care resources.

In 2011 the Department of Health published an investigation into digital preoperative assessment. It suggested that £65 million could be saved each year if this was adopted by 20% of the NHS. Our research suggests it hasn't been, presenting the commercial opportunity. With increasing use of the internet and the NHS moving to digital processes, the time is now.

Pre-procedure or preoperative assessment is usually paper based and completed by a nurse. This can take up to an hour. We operate a suite of products, hosted in the cloud, which aims to be efficient for clinicians and patients while reducing costs. Patients enter their information, then share it with their health care provider.

The NHS performs 10 million procedures each year. Ultraprep includes assessment for operations, endoscopies, cardiac cath lab and interventional radiology procedures. We are trialling with a private sector company and we're in talks with the Department for International Trade for their export support programme.

We feel we've gained good traction in the market given the barriers to entry for innovative products in the NHS. New product ideas for development have been identified using the initial software platform.

THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE BY THE COMPANY RAISING FINANCE AS IDENTIFIED ABOVE (THE "COMPANY") IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY AND SUBJECT TO THESE TERMS AND CONDITIONS.  CROWDCUBE CAPITAL LTD IS AUTHORISED BY THE FCA AND CARRIES OUT DUE DILIGENCE ON EACH COMPANY THAT LISTS ON CROWDCUBE AS SET OUT HERE.
 
This investment opportunity is not an offer to the public and is only available to registered members of Crowdcube.com who have qualified and categorised themselves as able to invest.  The investment opportunity is not directed at persons located in the United States, Canada or Japan. Any person resident outside the United Kingdom who wishes to view these materials must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict access.
In particular, unless otherwise determined by the Company and permitted by applicable law and regulation, it is not intended, subject to certain exceptions, that any offering of the securities mentioned in such materials (the "Securities") by the Company would be made, or any documentation be sent in or into, the United States, Canada or Japan.  There will be no public offering of the Securities in the United States.
 
In order to access the pitch you must first become a qualifying member of Crowdcube on the basis of your status as either (i) self-certified ‘high net worth investor’, (ii) certified ‘sophisticated investor’, (iii) self-certified as a ‘sophisticated investor’ or (iv) certified as a ‘restricted investor’, in each case in accordance with the FCA’s Conduct of Business Sourcebook Chapter 4.7.  Potential investors are encouraged to "cross examine" the Company by interactive due diligence and use of the available online forums to bring the "wisdom of the crowd" to bear.  Accessing the pitch also means you agree to Crowdcube’s most recent website terms and conditions and investor terms and conditions, which include Crowdcube's limitation of liability.
 
If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.  Crowdcube’s or the Issuer’s press announcements and this information page do not constitute an offer to sell securities of the Company.  Further, it does not constitute a recommendation by the Company, Crowdcube or any other party to sell or buy securities in the Company.
 
By registering or logging into Crowdcube.com to view the investment opportunity, you certify that you are legally entitled to view the investment opportunities, are an authorised investor and you agree to all applicable terms and conditions on this website, including this disclaimer.

To see the rest of the Ultramed pitch, join now.
It’s free, quick and easy.

Join

Already registered? Log in

To see the rest of the Ultramed pitch, join now.
It’s free, quick and easy.

Ultramed

Join to read more information about the Ultramed team, documents, and what other investors are saying about the pitch.

If you choose to invest we won’t take your money until the pitch closes and you can cancel your investment at any time.

Crowdcube is a leading investment crowdfunding platform

Successfully Invested
£689m+
Registered Investors
763k+